Varenicline: Quantifying the risk [2]

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 12, 2011, Pages 1404-

  Takagi, Hisato ^a   Umemoto, Takuya ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VARENICLINE;

CARDIOVASCULAR DISEASE; HUMAN; INTERMETHOD COMPARISON; LETTER; MANTEL HAENSZEL TEST; META ANALYSIS (TOPIC); PETO METHOD; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; TOBACCO;

EID: 80052527286     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.111-2063     Document Type: Letter

References (2)

1. Singh S., Loke Y.K., Spangler J.G., et al. Risk of serious adverse cardiovascular events associated with varenicline: A systematic review and meta-analysis. CMAJ 2011;183:1359-1366
2. Deeks JJ, Higgins JP, Altman DG, editors. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). Available: www. cochrane-handbook.org (accessed 2011 July 5).